Cadila sells their animal healthcare division at 2’921 cr. which translates into P/sales ~ 5.7x (FY20 sales ~ 513 cr.). The networth of the division was 2’203.6 cr. (as of March 31, 2020). Interestingly, Cadila will continue pursuing their investments into US and certain European markets for animal health. There is a lot of buzz in animal healthcare these days. This transaction is subject to shareholder approval.
Disclosure: Invested (position size here). Sold some shares today to bring position size closer to target.